Skip to main content
. 2012 Jan;5(1):3–12. doi: 10.1177/1756285611428503

Figure 1.

Figure 1.

Study design.

Deviations of ±3 days were permitted for Weeks 4 and 12, and deviations of ±7 days were permitted at Weeks 24, 36, 48, 60, 72, 84 and 96.

IFN, interferon; MRI, magnetic resonance imaging; sc, subcutaneous; tiw, three times weekly.